Replication of the Heads Up Atopic Dermatitis Trial With Registry Data
NCT06937788
·
clinicaltrials.gov ↗
RECRUITING
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Upadacitinib
BIOLOGICAL:
Dupilumab
Sponsor
Technische Universität Dresden